Welcome to our dedicated page for Amer Shared Hosp news (Ticker: AMS), a resource for investors and traders seeking the latest updates and insights on Amer Shared Hosp stock.
American Shared Hospital Services (AMS: NYSE) delivers innovative financing solutions for advanced cancer treatment technologies, including Gamma Knife radiosurgery and proton beam therapy systems. This page provides investors and healthcare professionals with timely updates on AMS's strategic partnerships, financial performance, and technology deployments.
Access curated press releases and news articles covering AMS's domestic operations and international joint ventures in Latin America. Track developments in radiation therapy financing, equipment upgrades, and oncology service expansions. Our repository ensures stakeholders stay informed about AMS's role in making cutting-edge cancer treatment accessible worldwide.
Explore updates on key areas: quarterly earnings reports, collaborations with medical institutions, regulatory milestones, and new technology implementations like Elekta's Esprit systems. Bookmark this page for direct access to verified information supporting informed decisions about AMS's market position and healthcare impact.
American Shared Hospital Services (NYSE: AMS) reported Q3 2025 results on November 13, 2025: Q3 revenue $7.2M (+2.5% period over period) and adjusted EBITDA $1.94M (+42.3% YoY). Q3 direct patient services revenue rose 9.4% to $4.0M and represented 56% of sales. Nine-month revenue was $20.4M (+5.6% YoY) with direct patient care revenue up 36.5% to $10.7M. The company signed a 10-year extension and Esprit upgrade with an existing health system and cited new centers in Puebla and planned Guadalajara startup in Q2 2026. Cash totaled $5.3M at Sept 30, 2025 after $7.5M CapEx.
American Shared Hospital Services (NYSE American: AMS) will hold a conference call to discuss third quarter 2025 financial results on November 13, 2025 at 1:00 PM ET. The company will issue the Q3 2025 press release before market open on November 13, 2025. Domestic callers should dial 1-844-413-3972; international callers should dial 1-412-317-5776 and join the American Shared Hospital Services call.
A simultaneous webcast will be available at www.ashs.com or via the direct webcast link. A replay will be available by phone at 1-855-669-9658 or 1-412-317-0088 (access code 7027755) through November 20, 2025, and on the company website.
American Shared Hospital Services (NYSE American: AMS) reported Q2 2025 financial results, with total revenue increasing 16% sequentially to $7.07 million, a slight 0.2% increase year-over-year. The company's direct patient services segment grew 11% year-over-year to $3.5 million, while medical equipment leasing revenue declined 8% to $3.57 million.
Q2 2025 resulted in a net loss of $280,000 ($0.04 per share), compared to net income of $3.6 million in Q2 2024, which included a one-time gain. Adjusted EBITDA was $1.7 million, down from $2.01 million in Q2 2024. The company maintains a strong balance sheet with $11.33 million in cash and shareholders' equity of $24.48 million ($3.78 per share).
Strategic expansion continues with a new Esprit installation in Guadalajara, Mexico, and Certificate of Need approvals for radiation therapy centers in Rhode Island.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, has scheduled its Q2 2025 earnings conference call for August 13, 2025, at 1:00 PM ET. The company will release its financial results before market opens on the same day.
Investors can join the call by dialing 1-844-413-3972 (domestic) or 1-412-317-5776 (international). A webcast will be available through the company's website. A replay will be accessible until August 20, 2025, using access code 3350902.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, has scheduled its first quarter 2025 financial results conference call for May 15th at 12:00 PM ET. The financial results press release will be issued before market opening on the same day.
Domestic participants can dial 1-844-413-3972, while international callers should use 1-412-317-5776. The call will be accessible via webcast through the company's website or directly via the provided link. A replay will be available until May 22, 2025, through multiple channels including the company's website.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, has announced its Annual Meeting of Shareholders scheduled for Thursday, June 26, 2025, at 9:00 a.m. CT. The meeting will be held in-person at 3041 Woodcreek Drive, #200, Downers Grove, IL 60515. The company has set April 28, 2025 as the record date for determining shareholders eligible to receive notice and vote at the Annual Meeting.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, has announced its participation in the upcoming Planet MicroCap Showcase: VEGAS 2025. The company's presentation is scheduled for Wednesday, April 23, 2025, at 12:00 PM ET.
Executive Chairman Ray Stachowiak and CEO Gary Delanois will lead the presentation and conduct a Q&A session. The event will be held at the Paris Hotel & Casino in Las Vegas, with opportunities for 1x1 investor meetings on Thursday, April 24, 2025. Interested parties can access the live presentation through a provided webcast link, and recordings will be available on the conference platform afterward.
American Shared Hospital Services (NYSE American: AMS) reported strong financial results for FY 2024, with revenue increasing 32.9% to $28.3 million. The company's direct patient services revenue saw a remarkable 253.4% increase to $12.6 million, while leasing segment revenue decreased 12.1% to $15.6 million.
Net income attributable to AMS surged 258.4% to $2.2 million ($0.34 per diluted share) in FY 2024. Adjusted EBITDA grew 8.5% to $8.9 million. The company expanded its footprint through strategic acquisitions, including three radiation therapy centers in Rhode Island and a new facility in Puebla, Mexico.
Q4 2024 showed mixed results with revenue up 59.2% to $9.1 million, but recorded a net loss of $1.3 million due to increased reserves for impaired assets and removal costs of $2.9 million in the leasing segment.
American Shared Hospital Services (NYSE American: AMS), a provider of stereotactic radiosurgery and advanced radiation therapy cancer treatment services, has scheduled its Fourth Quarter and Full Year 2024 earnings conference call for April 4th at 1:00 PM ET.
The financial results press release will be issued before market opening on April 4th. Investors can participate through:
- Domestic dial-in: 1-844-413-3972
- International dial-in: 1-412-317-5776
- Webcast: Available through www.ashs.com
A replay will be accessible until April 11, 2025, via phone (1-877-344-7529 or 1-412-317-0088, access code 2964909) and the company website.
FAQ
What is the current stock price of Amer Shared Hosp (AMS)?
What is the market cap of Amer Shared Hosp (AMS)?
